Portfolio: Highlights
MPM invests in biotechnology, specialty pharma, medical technology, and related companies that provide innovative medical products and requisite services to the healthcare industry -- irrespective of geography, stage of development and therapeutic area.
Alnara Pharmaceuticals
Focused on developing non systemic protein therapeutics for the treatment of metabolic diseases
EKR Holdings, Inc.
Pain management and oncology products
Epizyme, Inc.
Second generation epigenetic drug discovery and development company
ForteBio, Inc.
Protein quantification and kinetics
iPierian
Drug discovery and development company harnessing cellular reprogramming breakthroughs
NeuroTherapeutics Pharma, Inc.
Developing therapies for diseases associated with central nervous system (CNS) hyper-excitability
Pacira Pharmaceuticals, Inc.
Sustained-release drug delivery technologies
Proteon Therapeutics
Renal and vascular disease therapies
Rhythm Pharmaceuticals
Developing peptide therapeutics that address unmet needs in metabolic diseases
TriVascular, Inc.
Novel endovascular repair devices to treat abdominal aortic aneurysms
BioMarin Pharmaceuticals
Biopharmaceuticals for serious diseases and medical conditions
Biovitrum AB
Biopharmaceuticals for metabolic & blood disorders
Caliper Technologies Corp.
Cutting edge technologies for life science researchers.
Idenix Pharmaceuticals, Inc.
Anti-HIV and HBV therapy
Intercell AG
Vaccines for the prevention and treatment of infectious diseases.
Omrix Biopharmaceuticals, Inc.
Innovative biosurgical and passive immunotherapy products
Pharmasset, Inc.
Exited via the public markets
Rigel
Novel small-molecule drugs for inflammatory/autoimmune diseases and cancer.
ViaCell
Acquired by PerkinElmer
Alsius Corporation
Acquired by Zoll Medical, Inc.
Barrier Therapeutics, Inc.
Acquired by Stiefel Laboratories, Inc.
CoTherix
Acquired by Actelion
Cryocor, Inc.
Acquired by Boston Scientific Corp.
HemoSense
Acquired by Inverness Medical Innovations
Hypnion
Acquired by Lilly
Idenix Pharmaceuticals, Inc.
Groundbreaking partnership with Novartis
IDUN Pharmaceuticals, Inc.
Early acquisition by Pfizer
Peplin Limited
Acquired by LEO Pharma
Rinat Neuroscience Corp.
Genentech spinout acquired by Pfizer
TransForm
Acquired by J&J
ViaCell
Acquired by PerkinElmer